These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 9989644)
1. Value of different methods for the characterisation of Aspergillus terreus strains. Rath PM; Kamphoff S; Ansorg R J Med Microbiol; 1999 Feb; 48(2):161-166. PubMed ID: 9989644 [TBL] [Abstract][Full Text] [Related]
2. Differentiation of Aspergillus ustus strains by random amplification of polymorphic DNA. Rath PM; Petermeier K; Verweij PE; Ansorg R J Clin Microbiol; 2002 Jun; 40(6):2231-3. PubMed ID: 12037094 [TBL] [Abstract][Full Text] [Related]
3. Phenotypic and genotypic characterization of reference strains of the genus Aspergillus. Rath PM Mycoses; 2001 May; 44(3-4):65-72. PubMed ID: 11413925 [TBL] [Abstract][Full Text] [Related]
4. Environmental and clinical epidemiology of Aspergillus terreus: data from a prospective surveillance study. Rüping MJ; Gerlach S; Fischer G; Lass-Flörl C; Hellmich M; Vehreschild JJ; Cornely OA J Hosp Infect; 2011 Jul; 78(3):226-30. PubMed ID: 21440331 [TBL] [Abstract][Full Text] [Related]
5. Characterization of clinical strains of Aspergillus terreus complex: molecular identification and antifungal susceptibility to azoles and amphotericin B. Escribano P; Peláez T; Recio S; Bouza E; Guinea J Clin Microbiol Infect; 2012 Feb; 18(2):E24-6. PubMed ID: 22128886 [TBL] [Abstract][Full Text] [Related]
6. Molecular typing of Aspergillus terreus isolates by random amplification of polymorphic DNA. Symoens F; Bouchara JP; Heinemann S; Nolard N J Hosp Infect; 2000 Apr; 44(4):273-80. PubMed ID: 10772835 [TBL] [Abstract][Full Text] [Related]
7. In vitro susceptibilities of Aspergillus spp. causing otomycosis to amphotericin B, voriconazole and itraconazole. Kaya AD; Kiraz N Mycoses; 2007 Nov; 50(6):447-50. PubMed ID: 17944704 [TBL] [Abstract][Full Text] [Related]
8. Comparison of the activities of amphotericin B, itraconazole, and voriconazole against clinical and environmental isolates of Aspergillus species. Misra R; Malik A; Singhal S Indian J Pathol Microbiol; 2011; 54(1):112-6. PubMed ID: 21393890 [TBL] [Abstract][Full Text] [Related]
10. Molecular epidemiology and in-vitro antifungal susceptibility of Aspergillus terreus species complex isolates in Delhi, India: evidence of genetic diversity by amplified fragment length polymorphism and microsatellite typing. Kathuria S; Sharma C; Singh PK; Agarwal P; Agarwal K; Hagen F; Meis JF; Chowdhary A PLoS One; 2015; 10(3):e0118997. PubMed ID: 25781896 [TBL] [Abstract][Full Text] [Related]
11. Comparison of the Sensititre YeastOne colorimetric antifungal panel and Etest with the NCCLS M38-A method to determine the activity of amphotericin B and itraconazole against clinical isolates of Aspergillus spp. Martín-Mazuelos E; Pemán J; Valverde A; Chaves M; Serrano MC; Cantón E J Antimicrob Chemother; 2003 Sep; 52(3):365-70. PubMed ID: 12917236 [TBL] [Abstract][Full Text] [Related]
12. Epidemiology of Aspergillus terreus at a university hospital. Baddley JW; Pappas PG; Smith AC; Moser SA J Clin Microbiol; 2003 Dec; 41(12):5525-9. PubMed ID: 14662934 [TBL] [Abstract][Full Text] [Related]
13. Mutations in the cyp51A gene and susceptibility to itraconazole in Aspergillus fumigatus serially isolated from a patient with lung aspergilloma. Chen J; Li H; Li R; Bu D; Wan Z J Antimicrob Chemother; 2005 Jan; 55(1):31-7. PubMed ID: 15563516 [TBL] [Abstract][Full Text] [Related]
14. Comparison of the Sensititre YeastOne and CLSI M38-A2 Microdilution Methods in Determining the Activity of Amphotericin B, Itraconazole, Voriconazole, and Posaconazole against Aspergillus Species. Wang HC; Hsieh MI; Choi PC; Wu CJ J Clin Microbiol; 2018 Oct; 56(10):. PubMed ID: 30093391 [TBL] [Abstract][Full Text] [Related]
15. A comparison of methods of phenotypic and genotypic fingerprinting of Exophiala dermatitidis isolated from sputum samples of patients with cystic fibrosis. Rath PM; Müller KD; Dermoumi H; Ansorg R J Med Microbiol; 1997 Sep; 46(9):757-62. PubMed ID: 9291887 [TBL] [Abstract][Full Text] [Related]
16. Rep-PCR and RAPD-PCR fingerprinting of Aspergillus terreus. Mutschlechner W; Grif K; Blum G; Lass-Flörl C Med Mycol; 2013 Nov; 51(8):876-9. PubMed ID: 23758105 [TBL] [Abstract][Full Text] [Related]
17. Activity of micafungin (FK463) against an itraconazole-resistant strain of Aspergillus fumigatus and a strain of Aspergillus terreus demonstrating in vivo resistance to amphotericin B. Warn PA; Morrissey G; Morrissey J; Denning DW J Antimicrob Chemother; 2003 Apr; 51(4):913-9. PubMed ID: 12654746 [TBL] [Abstract][Full Text] [Related]
18. Evolutionary relationships among Aspergillus terreus isolates and their relatives. Varga J; Tóth B; Kocsubé S; Farkas B; Szakács G; Téren J; Kozakiewicz Z Antonie Van Leeuwenhoek; 2005 Aug; 88(2):141-50. PubMed ID: 16096690 [TBL] [Abstract][Full Text] [Related]
19. Comparison of restriction fragment length polymorphism, microsatellite length polymorphism, and random amplification of polymorphic DNA analyses for fingerprinting Aspergillus fumigatus isolates. Bart-Delabesse E; Sarfati J; Debeaupuis JP; van Leeuwen W; van Belkum A; Bretagne S; Latge JP J Clin Microbiol; 2001 Jul; 39(7):2683-6. PubMed ID: 11427596 [TBL] [Abstract][Full Text] [Related]
20. Genetic re-identification and antifungal susceptibility testing of Aspergillus section Nigri strains of the BCCM/IHEM collection. Hendrickx M; Beguin H; Detandt M Mycoses; 2012 Mar; 55(2):148-55. PubMed ID: 21929560 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]